SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Advanced Cell Technology Announces Approval to Treat Additional Stargardt’s Disease Patients With Higher RPE Dosage in Both U.S. and European Clinical Trials